KYVERNA THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - KYTX
Portfolio Pulse from
ClaimsFiler reminds investors of the February 7, 2025 deadline to file lead plaintiff applications in a class action lawsuit against Kyverna Therapeutics, Inc. (KYTX) related to its February 2024 IPO.
December 28, 2024 | 4:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kyverna Therapeutics faces a class action lawsuit related to its February 2024 IPO, with a lead plaintiff deadline set for February 7, 2025.
The class action lawsuit against Kyverna Therapeutics is likely to negatively impact its stock price in the short term due to potential legal liabilities and investor concerns. The deadline for lead plaintiff applications is February 7, 2025, which may increase market uncertainty.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100